Skip to main content
MEDICALSYSTEM BIOTECHNOLOGY CO., LTD logo

MEDICALSYSTEM BIOTECHNOLOGY CO., LTD — Investor Relations & Filings

Ticker · 300439 ISIN · CNE100001Z25 LEI · 3003007XTAWFVR8ASC23 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,715 across all filing types
Latest filing 2022-08-19 Legal Proceedings Report
Country CN China
Listing Shenzhen Stock Exchange 300439

About MEDICALSYSTEM BIOTECHNOLOGY CO., LTD

https://www.nbmksw.com

MedicalSystem Biotechnology Co., Ltd. specializes in the research, development, production, and distribution of in vitro diagnostic (IVD) products. The company offers a comprehensive portfolio that includes biochemical reagents, chemiluminescence immunoassay systems, molecular diagnostic kits, and point-of-care testing (POCT) solutions. Its product line covers a wide range of clinical applications such as liver function, kidney function, blood lipids, and cardiovascular markers. MedicalSystem is recognized for its integrated business model, which combines the manufacturing of high-quality diagnostic instruments with a vast array of compatible reagents. Additionally, the company provides third-party medical laboratory services to healthcare institutions. By focusing on technological innovation and standardized production, MedicalSystem supports clinical laboratories in achieving accurate and efficient diagnostic results for improved patient care.

Recent filings

Filing Released Lang Actions
关于收到《传票》暨诉讼事项的进展公告
Legal Proceedings Report Classification · 100% confidence The document is a public announcement from 美康生物科技股份有限公司 regarding the receipt of a legal summons (传票) and updates on ongoing litigation involving the company and its subsidiaries. It details the background of the lawsuit, court decisions, appeals, and the upcoming court hearing date. There is no financial data, earnings information, or report publication mentioned. The content focuses solely on legal proceedings and litigation updates. Therefore, this document fits the category of Legal Proceedings Report (LTR). The document length is 2884 characters, which is consistent with a detailed announcement but not a full financial report or other types of filings.
2022-08-19 Chinese
关于公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acquisition of medical device registration certificates issued by a regulatory authority (Zhejiang Provincial Drug Administration). It includes details about the certificates, their validity, and the expected impact on the company's business. The document is relatively short (1372 characters) and does not contain financial statements, earnings data, or detailed financial analysis. It is an official announcement about a regulatory approval rather than a financial report or management discussion. Therefore, it fits best into the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-08-12 Chinese
关于公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acquisition of a medical device registration certificate issued by the National Medical Products Administration. It includes details about the certificate, product, and potential impact on company performance. The document is short (926 characters) and serves as a regulatory announcement rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or voting results. It is not an annual or interim report, nor a call transcript or capital update. The content fits best under a general regulatory announcement category.
2022-07-26 Chinese
关于使用部分闲置募集资金进行现金管理到期赎回并再次进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from 美康生物科技股份有限公司 regarding the progress of using part of idle raised funds for cash management, including details of matured redemptions and new cash management investments. It includes specifics on amounts, dates, investment products, risk control measures, and approvals by the board and supervisory committee. The document is relatively short (3029 characters) and focuses on the update of cash management activities related to idle raised funds, not a full financial report or earnings release. It is not a report itself but an announcement of ongoing financing/capital management activities. Therefore, it fits best under Capital/Financing Update (CAP).
2022-07-26 Chinese
关于公司及子公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acquisition of medical device registration certificates by the company and its subsidiary. It includes details about the certificates, their validity, and the expected impact on the company's business. The document is relatively short (1458 characters) and does not contain financial statements or detailed financial analysis. It is an official announcement about regulatory approvals and their potential business impact, not a financial report or detailed management discussion. Therefore, it fits best into the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-07-13 Chinese
关于公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acquisition of a medical device registration certificate issued by a regulatory authority (Zhejiang Provincial Drug Administration). It includes details about the certificate, its validity, and the expected impact on the company's business. The document is short (862 characters) and does not contain financial statements, management discussion, or detailed financial data. It is an official announcement about a regulatory approval rather than a financial report or management update. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-07-04 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.